- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05942144
Exercise-snacks at Work: Impact on Cardiometabolic Parameters
Exercise-snacks: an Effective Strategy to Break Sitting Time and Improve Cardiometbaolic Health in Sedentary Overweight Office Workers
Study Overview
Status
Intervention / Treatment
Detailed Description
Backgrounds: Very short (< 1 minute) and intense exercises, entitled "exercise-snacks", have been reported to be effective 1) in improving physical fitness over 6 weeks and 2) in improving vascular function and lowering blood glucose levels over one day. These studies were all carried out in the laboratory. The question therefore arises as to whether these acute vascular and metabolic benefits, as well as those on physical fitness, are sustainable over time following a chronic "exercise-snacks" program applicable in the professional environment to sedentary, overweight people.
Aims of this project is therefore to measure the effects of an "exercise-snacks" type physical activity program in the workplace of administrative staff on the cardio-metabolic health and sedentary behaviour of staff.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Avignon, France, 84000
- Avignon University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- administrative staff,
- age between 30 and 60,
- body mass index ≥25kg/m²,
- sedentary time ≥7h/day,
- minimum 3 working days on site,
- no known cardiovascular or metabolic pathology, social security affiliation or benefit,
- ability and willingness to give free, written and informed consent.
Exclusion Criteria:
- pregnant or breast-feeding women,
- anti-hypertensive treatment, beta-blockers and anti-diabetics,
- known contraindications to physical activity (articular, cardiac or other),
- exercise-induced asthma,
- lack of motivation of subjects posing problems of compliance and adherence to the exercise program,
- participation in a study in the preceding 3 months, ongoing participation in a clinical trial.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise-snacks group
They will perform a "exercise-snacks" program and receive information about physical activity
|
Subjects in the exercise-snacks group will perform 4 "exercise-snacks" sessions per working day for 4 weeks.
These sessions will consist of 80 one-to-one walks to be completed as quickly as possible.
They will also receive information about their attitudes to physical activity.
|
|
No Intervention: Control group
They will maintain their usual lifestyle until the end of the study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in aerobic fitness
Time Frame: at inclusion, at the end of the 4-weeks program and 1 month following the end of the program
|
Aerobic fitness will be assessed via the Chester step test's prediction of VO2max
|
at inclusion, at the end of the 4-weeks program and 1 month following the end of the program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence of staff in the experimental group by analyzing accelerometric data.
Time Frame: during the 4-weeks program
|
Total number of exercise-snacks performed during the 4-week program by analysing accelerometers data
|
during the 4-weeks program
|
|
Intensity of exercise-snacks
Time Frame: during the 4-weeks program
|
Heart rate during exercise-snacks in % heart rate max
|
during the 4-weeks program
|
|
Changes in flow mediated dilation of superficial femoral artery
Time Frame: at inclusion, at the end of the 4-weeks program
|
measured by echocardiography (Vivid Q, GE) , in %
|
at inclusion, at the end of the 4-weeks program
|
|
Changes in peak shear rate of superficial femoral artery
Time Frame: at inclusion, at the end of the 4-weeks program
|
measured by echocardiography (Vivid Q, GE) during hyperemia, in s-1
|
at inclusion, at the end of the 4-weeks program
|
|
Changes in nitrate mediated dilation of superficial femoral artery
Time Frame: at inclusion, at the end of the 4-weeks program
|
by echocardiography (Vivid Q, GE), in %
|
at inclusion, at the end of the 4-weeks program
|
|
Changes in superficial femoral artery compliance
Time Frame: at inclusion, at the end of the 4-weeks program
|
by echocardiography (Vivid Q, GE), in mm2 mmHg-1
|
at inclusion, at the end of the 4-weeks program
|
|
Changes in carotid intima-thickness
Time Frame: at inclusion, at the end of the 4-weeks program
|
by echocardiography (Vivid Q) in mm
|
at inclusion, at the end of the 4-weeks program
|
|
Changes in carotid compliance
Time Frame: at inclusion, at the end of the 4-weeks program
|
by echocardiography (Vivid Q) in mm2 mmHg-1
|
at inclusion, at the end of the 4-weeks program
|
|
Changes in carotid-femoral pulse wave velocity
Time Frame: at inclusion, at the end of the 4-weeks program
|
by Sphygmocor, in m.s-1
|
at inclusion, at the end of the 4-weeks program
|
|
Changes in post-occlusive skin perfusion
Time Frame: at inclusion, at the end of the 4-weeks program
|
by Laser Doppler (Perimed), in perfusion unit, in area under the curve, in time to peak
|
at inclusion, at the end of the 4-weeks program
|
|
Changes in blood pressure
Time Frame: at inclusion, at the end of the 4-weeks program and 1 month following the end of the program
|
systolic, diastolic, mean and pulsed
|
at inclusion, at the end of the 4-weeks program and 1 month following the end of the program
|
|
Changes in mean amplitude of glycemic excursions
Time Frame: one week before the beginning of the program and the first week of the program and the 2 lastest weeks of the program
|
measured by continuous glucose monitoring (FreeStyle), in mmol.L-1
|
one week before the beginning of the program and the first week of the program and the 2 lastest weeks of the program
|
|
Changes in heart rate
Time Frame: between the beginning and end of the 4-week exercise program and 4 weeks after the program.
|
Heart rate at rest, at the end of the Chester step test and during exercise
|
between the beginning and end of the 4-week exercise program and 4 weeks after the program.
|
|
Changes in level of habitual physical activity
Time Frame: between the start and end of the 4-week exercise program and 4 weeks after the program
|
Physical Activity questionnaire
|
between the start and end of the 4-week exercise program and 4 weeks after the program
|
|
Changes in fat mass
Time Frame: between the start and end of the 4-week exercise program and 4 weeks after the program
|
measured by InBody, in kg
|
between the start and end of the 4-week exercise program and 4 weeks after the program
|
|
Changes in lean mass
Time Frame: between the start and end of the 4-week exercise program and 4 weeks after the program
|
measured by InBody, in kg
|
between the start and end of the 4-week exercise program and 4 weeks after the program
|
|
Change in physical activity behaviour at work of staff
Time Frame: between the start and end of the 4-week exercise program.
|
Theory of planned behavior questionnaire, score range from 20 to 80 with higher scores mean a better outcome.
|
between the start and end of the 4-week exercise program.
|
|
Changes in rating of perceived exertion
Time Frame: between the start and end of the 4-week exercise program and 4 weeks after the program
|
measured during the Chester test, score range from 7 to 20 with higher scores mean a worse outcome.
|
between the start and end of the 4-week exercise program and 4 weeks after the program
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Agnès VINET, Avignon University - LaPEC
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AU-062023-AVJ
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on Exercise-snacks program
-
Chimei Medical CenterNot yet recruitingPhysical Inactivity | Prediabetes / Type 2 Diabetes | Sedentary BehaviorsTaiwan
-
University of British ColumbiaMcMaster UniversityRecruiting
-
University of British ColumbiaMcMaster UniversityRecruiting
-
University of British ColumbiaMcMaster UniversityRecruiting
-
Ivan PatrícioCIDEFES - Universidade Lusofona; Associação Casapiana de SolidariedadeActive, not recruitingChronic Pain | Cognition Disorders in Old Age | Physical Fitness in Older AdultsPortugal
-
Jinan University GuangzhouCompletedAdolescent Behavior | Smartphone Addiction | Sedentary BehaviorsHong Kong
-
Seoul National UniversityNot yet recruitingMetabolic Syndrome | Prediabetes
-
Beijing Sport UniversityNot yet recruitingCardiorespiratory Fitness | Cardiovascular FunctionChina
-
Universidad Metropolitana de Ciencias de la EducacionNot yet recruitingMental Health | Physical Inactivity | Cardiovascular Health | Mental Health Care | Sedentary BehaviorsChile